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Insulin signaling in the central nervous system influences satiety, counterregulation, and 
peripheral insulin sensitivity. Neurons expressing the Glut4 glucose transporter influence 
peripheral insulin sensitivity. Here, we analyzed the effects of insulin receptor (IR) signaling in 
hypothalamic Glut4 neurons on glucose sensing as well as leptin and amino acid signaling. By 
measuring electrophysiological responses to low glucose conditions, we found that the majority 
of Glut4 neurons in the ventromedial hypothalamus (VMH) were glucose excitatory neurons. 
GIRKO mice with a combined ablation of IR in Glut4-expressing tissues showed increased 
counterregulatory response to either 2-deoxyglucose-induced neuroglycopenia or systemic 
insulin-induced hypoglycemia. The latter response was recapitulated in mice with decreased 
VMH IR expression, suggesting that the effects on the counterregulatory response are likely 
mediated through the deletion of IRs on Glut4 neurons in the VMH. Using 
immunohistochemistry in fluorescently labelled hypothalamic Glut4 neurons, we show that IR 
signaling promotes hypothalamic cellular signaling responses to the rise of insulin, leptin, and 
amino acids associated with feeding. We conclude that hypothalamic Glut4 neurons modulate 
the glucagon counterregulatory response, and that IR signaling in Glut4 neurons is required to 
integrate hormonal and nutritional cues for the regulation of glucose metabolism. 
INTRODUCTION 
The re-emerging notion that insulin, acting through the central nervous system (CNS), controls 
peripheral insulin sensitivity raises the possibility of developing CNS-based approaches to treat 
insulin resistance, obesity, and type 2 diabetes. IR signaling in the CNS also has roles in the 
regulation of food intake 1, the counterregulatory response to hypoglycemia 2, gonadotropin 
release 3, peripheral glucose metabolism 4, leptin sensitivity 5, and neuronal plasticity 6. We 
previously identified a subset of neurons characterized by Glut4 glucose transporter expression 
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that are important for systemic insulin sensitivity 7. Indeed, mice with a collective ablation of IR 
in Glut4-expressing tissues (GIRKO), develop highly penetrant diabetes that recapitulates 
cardinal features of the human disease 7.  
In this study, we used GIRKO mice to study the role of CNS IR signaling in the response to 
glucose deprivation. Hypoglycemia is commonly observed in association with intensive insulin 
therapy 8,9. Restoration of normoglycemia following acute hypoglycemia requires effective 
sensing of low glucose levels and rapid activation of the counterregulatory hormone responses, 
particularly glucagon and epinephrine 2, in addition to other key metabolic hormones, such as 
leptin 10. Moreover, recurrent hypoglycemia can decrease the sympathoadrenal response, 
resulting in greater risk of severe hypoglycemia and hypoglycemia unawareness 8. Thus, 
understanding CNS-based mechanisms that initiate counterregulatory responses can help reduce 
or prevent hypoglycemia.  
It has been shown that neurons in the rodent mediobasal hypothalamus, which consists of the 
ventromedial (VMN) and arcuate nuclei (ARC), are important for glucose sensing, and that IR 
signaling modulates the counterregulatory response to neuroglycopenia 11,12. Nonetheless, the 
specific neuronal sub-types involved in this response is unclear 13. We previously showed that 
Glut4 neurons represent a distinct neuronal population that has a heterogeneous composition of 
neuronal markers and neurotransmitters 14. Upon toxin-mediated ablation of these neurons in the 
hypothalamus, mice develop anorexia and reduced insulin secretion that results in impaired 
glucose tolerance with fasting hyperglycemia 15. These data are consistent with the notion that 
hypothalamic Glut4 neurons are important mediators of insulin action. In this study, we 
investigated whether insulin receptor signaling on hypothalamic Glut4 neurons participate in the 
regulation of the counterregulatory response to hypoglycemia, using a combination of 
electrophysiology, hypoglycemic clamps, targeted neuroglycopenia and analysis of biochemical 
signaling pathways.  
Material and Methods  
Mice 
Gt(Rosa)26Sortm9(CAG-tdTomato)Hze, Gt(Rosa)26Sortm3(CAG-EYFP)Hze, ROSA26-EGFP, and wild type 
B6 mice were obtained from The Jackson Laboratories. Glut4 neurons were fluorescently 
labelled by breeding Rosa reporter mice with Glut4-Cre mice. GIRKO mice were generated as 
previously described 7. C57BL6 mice for the VMH insulin receptor knockdown studies were 
procured from Charles River. The procedures were approved by Indiana University, University 
of Utah, and Columbia University Animal Care and Utilization Committees.  
Evaluating the glucose responsiveness of hypothalamic Glut4-Expressing Neurons  
To determine whether hypothalamic Glut4-expressing neurons respond to fluctuating glucose 
levels, we conducted electrophysiological analyses on coronal brain slices (300 um) taken 
through the hypothalamus of three male Glut4-EYFP mice (8-10 weeks old). Briefly, the mice 
were sacrificed by decapitation, the brains were rapidly removed and slices were cut through the 
hypothalamus using a Leica VT1200 vibratome in an ice-cold, oxygenated (95% O2, 5%CO2) 
solution (in mM: 10 NaCl, 25 NaHCO3, 2.5 KCl, 10 D-glucose, 1.25 NaH2PO4, 195 sucrose, 2 
NaN3, 7 MgCl2, 1 CaCl2, pH 7.3). Three-four slices were prepared from each mouse. Prior to 
electrical recordings, the brain slices were maintained at room temperature for at least 1 h in 
oxygenated (95% O2, 5% CO2) artificial cerebrospinal fluid (aCSF) (in mM: 120 NaCl, 5 KCl, 
26 NaHCO3, 1.2 NaH2PO4, 2 CaCl2, 1 MgCl2, 5 D-glucose, pH 7.4). Mannitol was used to 
adjust the osmolality of the low glucose aCSF (0.1 mM or no glucose). Whole-cell patch 
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3
recordings were performed using borosilicate glass electrodes with resistance between 4 and 6M 
backfilled with an intracellular solution (in mM: 128 K-gluconate, 10 KCl, 10 HEPES, 0.1 
EGTA, 2 MgCl2, 3 ATP and 0.1 GTP, pH 7.3). Glut4 neurons in the VMN or POMC neurons in 
the ARC were identified by fluorescence and patch clamped under IR-DIC optics. Recordings 
were acquired with an Axopatch 700B amplifier, digitized and analyzed with pClamp10 software 
(Molecular Devices). 
Evaluating the counterregulatory response to neuroglycopenia 
Stereotaxic injections were performed as described previously 16. Briefly, 3-4 months old wild  
type (N=6) and GIRKO (N=6) mice were anesthetized and a unilateral microinjection guide 
cannula was stereotaxically implanted into the lateral ventricle (-0.3mm anterior and 1mm lateral 
to bregma and 2.2mm below the skull surface).   The mice were then allowed 1 week for 
recovery. We verified correct positioning of the cannula by injecting methylene blue (1%) after 
the animals were euthanized. We induced neuroglycopenia by acutely injecting the non-
metabolizable glucose analog, 2-deoxyglucose (2-DG; 1mg/mouse) intracerebroventricularly 
(icv) into the lateral ventricle. In the first experiment, we monitored blood glucose from a tail 
nick over the course of 5 hours following injection of 2-DG. In the second experiment, we 
collected blood samples to measure plasma glucagon levels 30 minutes after icv 2-DG injection.  
Evaluating the counterregulatory hormone response to systemic insulin-induced hypoglycemia in 
GIRKO mice  
Having demonstrated that hypothalamic Glut4 neurons are in fact glucose responsive, we 
proceeded to establish whether loss of insulin signaling in Glut4 tissues altered the hormone 
response to hypoglycemia. Approximately 4-5 days prior to the clamp procedure, wild type 
(N=6) and GIRKO (N=6) mice were anesthetized with isoflurane and a single catheter (MRE-25) 
was implanted into the jugular vein and tunneled subcutaneously as described previously 17. Four 
to five days later, hypoglycemic clamp studies were performed as described previously 11. 
Briefly, overnight fasted mice were connected to infusion pumps and allowed to recover for a 
period of ~2hrs prior to obtaining baseline blood samples through a tail nick. Subsequently, a 
bolus-constant insulin (20mU/kg/min) and variable 20% dextrose solution were infused 
intravenously to lower and maintain plasma glucose levels at ~50 mg/dl for 90 minutes. Blood 
samples were collected at 30 min intervals throughout the hypoglycemic clamp portion of the 
study for measurement of plasma glucagon and catecholamine responses, and at 90 min for 
plasma insulin levels. Erythrocytes from a donor mouse were washed, suspended in heparinized-
saline and infused over the course of the study to prevent volume depletion and anemia. At the 
end of the study, the animals were euthanized with an overdose of sodium pentobarbital. 
Identifying whether loss of insulin receptors in the VMH recapitulates the counterregulatory 
defects observed in GIRKO mice 
To better establish whether loss of insulin receptors in the VMH contributed to the amplified 
glucagon response observed in GIRKO mice, we locally knocked down insulin receptor 
expression in the VMH using an adeno associated viral vector that expresses an insulin receptor 
shRNA and enhanced GFP reporter under the control of a U6 promoter (Vector Biolabs, cat# 
shAAV-262287). This viral vector was shown to reduce insulin receptor expression in the VMH 
by ~45% (Supplemental Figure 2) 18. 0.5ul of the IR shRNA AAV was bilaterally microinjected 
into the VMH (-1.46mm AP, ±0.4mm ML and -5.2mm DV at an angle of 0°) of C57BL6 mice 
(N=6) under isoflurane anesthesia. An AAV expressing a non-specific scrambled RNA sequence 
was used as a negative control (N=5). Three weeks after viral inoculation, a vascular catheter 
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was implanted into the jugular vein were implanted.  The animals were then recovered for 4-5 
days before undergoing a hypoglycemic clamp as described above. 
Hormone analyses 
We used ELISA for insulin measurements (Millipore), and colorimetric assays for metabolite 
measurements 16. Plasma insulin and glucagon in blood samples collected during the clamp 
procedures were measured by radioimmunoassay (Millipore)  19 or ELISA (Mercodia, Winston 
Salem, NC). Catecholamines were measured by ELISA (Eagle Biosciences). 
Evaluating whether the hypothalamic Glut4 neurons response to insulin, leptin and amino acids 
signaling during feeding is affected in GIRKO mice.  
To determine whether loss of insulin receptor in hypothalamic Glut4-expressing neurons alters 
their ability to respond to insulin, leptin and amino acids, we used immunohistochemistry to 
quantify the activated downstream signaling targets, i.e. phospho-Akt (pAkt), phosphor-Stat3 
(pStat3), and phosphor-S6 (pS6), respectively, in the arcuate nucleus. Both wild type and 
GIRKO mice were fasted and refed before they were sacrificed. Their brains were harvested and 
immunohistochemically processed as previously described 16. We quantified the fluorescent 
signal intensity of pAkt/pStat3/pS6 and GFP from individual cells in the arcuate nucleus. Image 
J was used to quantify the fluorescence intensity and mark individual neurons. Glut4 neurons 
were identified by the green fluorescence, where the GFP signal intensity was used to identify 
Glut4+ neurons versus non-Glut4 neurons. Neurons were considered Glut4+ if the GFP integrated 
density (IntDen) exceeded 0.300 (arbitrary units, AU), while Glut4- neurons had a GFP IntDen 
less than or equal to 0.300. Phosphorylated Akt, Stat3, and S6 were used to gauge the activity of 
insulin, leptin, and amino acid signaling pathways, respectively. Plotting the results in groups of 
Glut4+ neuron versus non-Glut4 neurons from WT and GIRKO mice allowed us to quantify the 
signaling activity in individual cells, which serves as an unbiased way to assay hormone and 
nutrient sensitivity in Glut4+ versus non-Glut4 neurons. The antibodies used were procured from 
Cell Signaling Technology and ThermoFisher Scientific and include phosphor-Akt (Ser473) 
(D9E) XP Rabbit mAb (#4060) (RRID: AB_2315049) 20, phosphor-S6 ribosomal protein 
(Ser235/236) (D57.2.2E) XP Rabbit mAb (#4858) (RRID: AB_916156) 21, phosphor-Stat3 
(Tyr705) (D3A7) XP Rabbit mAb (#9145) (RRID: AB_2491009) 22, Alexa Fluor 555 goat anti-
rabbit IgG secondary antibody (#A27039) (RRID: AB_2536100) 23. Food intake. We measured 
food intake and feeding response as previously described 24,25. 
Statistical analyses 
We analyzed data with Student’s t–test or one–way or two-way ANOVA using GraphPad Prism 
software. We used the customary threshold of p < 0.05 to declare statistical significance.  
RESULTS 
Glut4 neurons in the hypothalamus are glucose responsive 
We characterized the glucose responsive nature of the Glut4 neurons using electrophysiology. 
We first validated the whole-cell patch-clamp technique using hypothalamic 
proopiomelanocortin (POMC) neurons (Supplemental Figure 1) 18, an established type of glucose 
excited neurons26-28. GFP labelled POMC neurons respond to glucopenia with hyperpolarization 
and reduced spontaneous firing frequency (Supplemental Figure 1A-D) 18. This is consistent with 
previous reports that identified POMC neurons as glucose-excitatory neurons 26-28, thus 
validating our experimental system. Next, we measured the electrophysiological response of 
Glut4 neurons to changing glucose concentrations by patch-clamping EYFP-labeled Glut4 
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5
neurons (with intact IR signaling) in the ventromedial nucleus of the hypothalamus (VMN) 
(Figure 1). When baseline glucose (5mM) was lowered to 0.1mM, Glut4 neurons responded with 
hyperpolarization and reduced spontaneous firing frequency (Figure 1A-B), which was restored 
to baseline measurement during the washout phase (Figure 1C-D). More measurements revealed 
that hypothalamic Glut4 neurons are a mixed population, the majority of these neurons are 
glucose-excited neurons (61.5%), while a smaller fraction of these Glut4 neurons are either 
glucose-inhibited (15.4%) or non-responsive (23.1%).  
Augmented hyperglycemic response to neuroglycopenia in GIRKO mice 
 We also assessed the glucagon response to neuroglycopenia in GIRKO mice following an 
intracerebroventricularly (icv) injection of 2-deoxyglucose (2-DG). After icv injection of 2-DG, 
WT mice developed hyperglycemia, a response that was greatly amplified in GIRKO mice 
throughout the 5-hr observation period (Figure 2A). The rise in glucose was accompanied by a 
nearly 50% increase in glucagon levels in the GIRKO mice, compared to WT mice (Figure 2B).  
To examine the signaling pathways mediating the amplified counterregulatory response seen 
in GIRKO mice, we measured levels of phospho-(p)Akt by western blotting of hypothalamic 
extracts dissected following icv 2-DG injection. Unexpectedly, overall pAkt was markedly 
increased in GIRKO hypothalamic samples (Figure 2C). In contrast, hippocampi collected from 
the GIRKO and control mice showed comparable amount of pAkt (Figure 2C). This supports the 
notion that hypothalamus is a critical site for sensing glucose. Next, we examined pAkt by 
immunohistochemistry, to localize the activation to a specific hypothalamic cell type. In these 
experiments, we used GIRKO mice in which Glut4 neurons had been labelled with Rosa26-
tdTomato 14. Using double staining with pAkt and Tomato (to label Glut4 neurons), we found 
that the increase in pAkt occurred largely, if not exclusively, in non-Glut4 neurons of GIRKO 
mice. Quantitative analysis of the results showed the percentage of pAkt-positive Glut4 neurons 
were ~one-third lower in the arcuate nucleus (ARC) of GIRKO mice, whereas the percentage of 
pAkt-positive non-Glut4 neurons was ~6-fold greater in GIRKO mice (Figure 2D). The aberrant 
Akt signaling in the non-Glut4 neurons may explain the exaggerated counterregulatory response 
in GIRKO mice experiencing neuroglycopenia.   
GIRKO mice have an enhanced counterregulatory response to systemic insulin-induced 
hypoglycemia 
Glut4 is expressed in glucose-sensing neurons 29, but it’s not known whether IR signaling in 
Glut4 neurons regulates glucose sensing. To address this question, we investigated the hormonal 
response to systemic insulin-induced hypoglycemia in GIRKO mice. Our previous work showed 
that GIRKO mice develop diabetes with age 7. To avoid the potential confounders of 
hyperglycemia and beta cell failure, we selected chow-fed euglycemic GIRKO and littermate 
controls for these studies.   
Despite matched plasma glucose and insulin concentrations during the hypoglycemia clamp 
(Figure 3A-B), the glucose infusion rate (GIR) needed to maintain plasma glucose levels at ~ 50 
mg/dl in the GIRKO mice was nearly 75% lower compared to the WT mice (Figure 3C). The 
decrease in the GIR corresponded to an increase in glucagon secretion (Figure 3D) during the 
hypoglycemic clamp, but the epinephrine and norepinephrine responses were not affected.  
Improvements in the glucagon response to hypoglycemia stem from a reduction in VMH insulin 
receptor expression  
Our results show that GIRKO mice responded to insulin-induced hypoglycemia with an 
increased counterregulatory response. However, GIRKO mice have global IR deficiency and the 
defect is not confined to the brain. In order to rule out the possibility that systemic insulin 
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resistance led to improvements in glucagon secretion during hypoglycemia in GIRKO mice, we 
performed hypoglycemic clamp studies on mice with VMH-specific IR knockdown. This 
nucleus was targeted because our previous work showed that, within the hypothalamus, Cre 
activity of the Glut4-Cre transgene was concentrated in the VMH 15. Therefore, we selectively 
knocked down IR in the VMH (IR-KD). Despite similar plasma glucose levels (Figure 4A), 
VMH IR-KD mice required significantly less exogenous glucose during the clamp (Figure 4B). 
The reduction in GIR observed in the VMH IR-KD mice corresponded to improvements in the 
glucagon response (Figure 4C). Plasma epinephrine responses were not significantly different 
during the clamp (Figure 4D). These results were consistent with those from the clamp studies in 
GIRKO mice (Figure 3). Therefore, we conclude that the exaggerated glucagon response to 
hypoglycemia observed in GIRKO mice is most likely due to a loss of insulin signaling in the 
VMH rather than increased peripheral insulin resistance.  
Regulation of feeding associated hormonal and nutrient signaling by IR in Glut4 neurons 
Thus far, we established that Glut4 neurons play an important role in regulating the glucagon 
response to hypoglycemia. We then asked whether Glut4 neurons respond to other hormonal and 
nutrient-related signals associated with feeding, such as leptin and amino acids. We took 
advantage of the ability to label Glut4 neurons in WT and GIRKO mice using a Rosa-GFP 
reporter allele to investigate these questions. During fasting, leptin and amino acid levels are 
low, resulting in low basal signaling activity. After refeeding, the increased availability of 
nutrients triggers hormone release, therefore how the animals respond to the surge reflects the 
nutritional and hormonal sensitivity.  We decided to use the fast-refeeding paradigm as opposed 
to injecting hormones directly because this is a more physiologically relevant setting to capture 
the in vivo response. We subjected mice to fasting and re-feeding, then performed 
immunohistochemistry on hypothalamic sections using readouts of insulin (pAkt), leptin 
(pStat3), or amino acid signaling (pS6) (red), as well as GFP to identify Glut4-expressing 
neurons (green). After re-feeding, we detected pAkt (red) in Glut4 neurons (green) of WT mice 
(Figure 5A, yellow arrowhead in the inset), whereas in GIRKO mice the intensity and co-
localization of pAkt in Glut4 neurons was markedly diminished (Figure 5A lower panel, separate 
green and red arrowheads, inset). These data indicate that most of the pAkt detected following 
re-feeding localizes to IR-containing Glut4 neurons in the arcuate nucleus (ARC) of WT mice, 
and that ablation of IR markedly blunts this response, thereby helping to validate the model’s 
utility to investigate the effects of IR signaling on other signaling pathways. 
Amino acid sensing in the CNS occurs primarily through the mTOR-S6K-S6 pathway 30 and 
thus we assessed pS6 immunohistochemistry in WT and GIRKO samples. Similar to the pStat3 
results, we detected a strong correlation between pS6 and Glut4 neurons in re-fed WT mice 
(Figure 5B, yellow arrowhead in the inset), whereas in GIRKO mice samples, pS6 
immunoreactivity was markedly attenuated, with a trend of increase in a subset of non-Glut4 
neurons (Figure 5B, separate green and red arrowheads, inset). 
Next, we analyzed pStat3 as a means to gauge leptin sensitivity. While pStat3 and Glut4 
(GFP) immunoreactivity showed substantial overlap (Figure 5C, yellow arrowhead in the inset), 
we observed a bimodal pStat3 pattern in re-fed GIRKO mice. pStat3 immunoreactivity was still 
detected in Glut4 neurons, whereas there was a marked activation in a subset of non-Glut4 
neurons (Figure 5C, separate green and red arrowheads, inset). The increased leptin sensitivity in 
non-Glut4 neurons of GIRKO mice might reflect: (i) a compensatory increase, or (ii) removal of 
an IR-dependent inhibitory signal arising from Glut4 neurons.   
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7
 Given the bimodal response of pStat3 to leptin (Figure 5D) in GIRKO mice, we assessed 
leptin responsiveness in vivo by measuring food intake after leptin injection in euglycemic WT 
and GIRKO mice. The GIRKO mice exhibited a blunted response to leptin (Figure 5D), 
suggesting that ablation of IR signaling in Glut4 neurons impairs leptin sensitivity despite the 
changes in non-Glut4 neurons.  
Taken together, GIRKO mice appear to have an abnormal response to nutrient availability, 
which may lead to aberrant feeding behavior. For instance, while neuroglycopenia increased 
food consumption in WT mice, the food consumption of GIRKO mice in response to both central 
saline and 2DG administration were similar (Figure 5E).  
Conclusion 
The findings of the present work contribute to our understanding of the contribution of insulin 
and Glut4 towards the counterregulatory response to hypoglycemia and nutrient sensing. We 
conclude that (i) Glut4 neurons are glucosensing neurons in the CNS; (ii) a decrease in IR 
signaling in Glut4 neurons blunts the glucagon response to hypoglycemia; and (iii) IR signaling 
in Glut4 neurons has unexpected effects on leptin and amino acid signaling in hypothalamic 
Glut4 as well as non-Glut4 neurons.  
DISCUSSION 
In previous studies, we showed that Glut4 neurons are indeed insulin-sensitive neurons and that 
they may play a role in integrating olfacto-sensory responses with metabolic cues 14. Moreover, 
in cell ablation experiments, we showed that hypothalamic Glut4 neurons regulate satiety, 
glucose homeostasis, and CNS sensing of hormones and nutrients 15. The present findings extend 
our previous work showing that hypothalamic Glut4 neurons are mostly glucose- excited neurons 
and that inhibition of IR function in the VMN of rodents increases the glucagon response to 
hypoglycemia 11.  
To better understand the characteristic of hypothalamic Glut4 expressing neurons, we 
performed electrophysiological studies to determine whether they were glucose responsive. The 
majority of these Glut4 neurons in the VMN decreased their activity in response to a reduction in 
glucose in the medium, suggesting they are glucose-excited neurons. A previous study has 
shown that insulin stimulates glucose uptake and promotes translocation of Glut4 to the neuron 
surface31. This suggests that during the early physiological response to hypoglycemia, when 
insulin secretion declines, a reduction in insulin action can decrease the translocation of GLUT4 
glucose transporters to the membrane in hypothalamic Glut4 neurons, thereby reducing glucose 
uptake and silencing neuronal activity. If these hypothalamic glucose excited neurons are indeed 
inhibitory GABAergic neurons, as has been shown previously 32, then a decrease in inhibitory 
output can enhance the counterregulatory hormone response. In the case of the GIRKO mice, a 
chronic reduction in IRs may decrease the activity of these glucose excited GABAergic neurons 
and ultimately, augment the counterregulatory response during hypoglycemia.  
The current data provides evidence that insulin may influence the activity of glucose 
responsive Glut4 neurons in the hypothalamus to modulate the counterregulatory hormone 
response to hypoglycemia. Specifically, loss of insulin receptors and signaling on Glut4 neurons 
in GIRKO mice results in an exaggerated glucagon response to insulin-induced hypoglycemia. 
As IRs are also knocked out in peripheral tissues of GIRKO mice, peripheral insulin resistance 
becomes a confounding factor. For this reason, we knocked down IR expression in the VMH of 
C57BL6 mice and found that this manipulation recapitulated the enhanced glucagon response 
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8
observed in the GIRKO mice. It is important to note that the chronic loss of IRs in the VMH can 
lead to impaired glucose tolerance after twelve weeks of knockdown, but not after 6 weeks of 
knockdown 33. In our VMH IR-KD mice, IR knockdown was only maintained for a period of 4 
weeks and therefore, the development of peripheral insulin resistance and impaired glucose 
tolerance was likely not a factor that augmented the glucagon response. Moreover, when we 
centrally administered the glucoprivic agent, 2-DG, into the brains of GIRKO mice, we observed 
an exaggerated hyperglycemic response that was coupled with an augmented glucagon response. 
These observations are consistent with the idea that the loss of insulin receptors in the brain and 
more specifically, in hypothalamic Glut4 neurons, leads to a decrease in inhibitory output which 
enhances glucagon secretion.  
In addition, these studies also show that in response to neuroglycopenia, there was greater 
phosphorylation of Akt in the hypothalamus of GIRKO mice compared to the hippocampus. 
Interestingly, while the cell-autonomous decrease of pAkt in Glut4 neurons of GIRKO mice was 
expected in this scenario, the marked increase of pAkt in non-Glut4 neurons has not been 
described. This change in pAkt could be engaged independently of the IR and may be due to 
many factors. For instance, this may be a result of the hormonal/metabolites feedback inputs to 
these non-Glut4 neurons. Nevertheless, further studies will be required to ascertain whether this 
ectopic Akt activation in non-Glut4 neurons is either necessary or sufficient to initiate the 
counterregulatory response.  
An unexpected finding of this work is the paradoxical activation of Stat3 and S6 signaling in 
non-Glut4 neurons following IR ablation in Glut4 neurons, suggesting that insulin signaling in 
Glut4 neuron dampens leptin and amino acid signaling in a cell-autonomous fashion. The finding 
emphasizes the integrative role of Glut4 neurons in energy homeostasis 34, while raising the 
possibility that the identification of the additional feedback cues emanating from these neurons 
will provide actionable points to increase leptin or nutrient sensitivity in the treatment of 
metabolic disorders 35. 
 Future work is warranted to investigate the circuitry of Glut4 neurons mediating the 
response to hypoglycemia, as Glut2 neurons of the nucleus tractus solitarius (NTS) are reported 
to link hypoglycemia detection to counterregulatory response 36. The finding that hyperglycemic 
response to 2DG is not concordant with blunted feeding response in the GIRKO is surprising. 
Similar findings were reported in the hindbrain catecholamine neurons 37. Therefore, whether the 
hindbrain is involved in the circuitry of Glut4 neurons mediating the hypoglycemia response will 
also be investigated. In conclusion, the findings of the present work contribute to mapping neural 
entities contributing to the regulation of energy homeostasis, as well as new insight into the 
pathophysiology of the counterregulatory response. 
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Figure 1. Glut4 neurons are glucose responsive neurons. (A) Glut4 neurons were identified 
using a fluorescent microscope. (B) Spontaneous action potentials (sAPs) were recorded in the 
whole-cell current-clamp mode in Glut4 neurons perfused sequentially with aCSF containing 5 
mM glucose (baseline), 0.1 mM glucose and 5 mM glucose (washout). Representative 30 s 
sections of a current-clamp recording from the same neuron in aCSF containing different 
extracellular glucose concentration were shown below. (C) Mean changes in membrane potential 
with changes in extracellular glucose concentration. (D) Mean fold changes in sAP frequency 
with changes in extracellular glucose concentration. Data show means ± SEM (n=8) (*= p<0.05, 
**= p<0.01, ***= p<0.001, paired t-test). 
Figure 2.  pAkt signaling after neuroglycopenia challenge. (A) Time course study of the 
hyperglycemic response after 2-DG icv injection in WT and GIRKO mice (n=7-10 per group). 
(B) Serum glucagon measurement after saline or 2-DG icv injection. Data show means ± SEM 
(n=9). (C) Western blot showing increased pAkt in GIRKO hypothalamus. (D) Quantification of 
the distribution of pAkt+ cells and Glut4 neurons in WT and GIRKO mice after 
neuroglycopenia. Data show means ± SEM (n=5) (*= p<0.05, **= p<0.01, ****= p<0.0001, 
2way ANOVA Sidak’s multiple comparison test).   
Figure 3. Increased counterregulatory response in GIRKO mice in hypoglycemic clamp 
studies. Plasma glucose (A) and insulin (B) concentration during the hypoglycemic clamp 
procedure were well matched between WT and GIRKO mice. Despite this, glucose infusion rates 
(C) were significantly lower in the GIRKO mice compared to WT. The glucagon response (D) 
was significantly increased in the GIRKO mice, but plasma epinephrine (E) and norepinephrine 
(F) responses were not significantly different. Data show means ± SEM (n=6) (*= p<0.05, ***= 
p<0.001, ****=P<0.0001, 2way ANOVA Sidak’s multiple comparison test).  
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Figure 4. Increased counterregulatory response in IR-KD mice in hypoglycemic clamp 
studies. Plasma glucose (A) concentrations were matched between Control and VMH IR 
knockdown (IR-KD) mice during the hypoglycemic clamp. Glucose infusion rates (B) were 
significantly lower in IR-KD mice. Plasma glucagon (C) and epinephrine (D) were measured 
during the clamp. Data show means ± SEM (n=5-6 per group) (*= p<0.05, 2way ANOVA 
Sidak’s multiple comparison test).  
Figure 5. Hormone and nutrient signaling in Glut4 neurons from GIRKO mice. (A-C) 
Immunohistochemistry with pAkt (A), pS6 (B), and pStat3 (C) and GFP in the ARC of WT and 
GIRKO mice. Following refeeding, integrated density of the fluorescent signal in Glut4- (black 
bars) and Glut+ (green bars) neurons was measured and plotted on the right. Data show means ± 
SEM (n=21-138 cells measured per group) (*= p<0.05, **= p<0.01, ****= p<0.0001, one-way 
ANOVA Tukey’s multiple comparisons test). (D) 24-hr food intake following leptin injection. 
Data show means ± SEM (n=7) (*= p<0.05, 2way ANOVA Bonferroni multiple comparisons). 
(E) Food intake measurement after saline or 2-DG ip injection. Data show means ± SEM (n=6) 
(***= p<0.001, 2way ANOVA Bonferroni multiple comparisons). 
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